21 May 2013
Keywords: MDRNA, Cequent, RNAi platform, M&A
Article | 06 April 2010
Two US RNAi-based drug discoverers and developers, MDRNA and Cequent Pharmaceuticals, have reached agreement to merge, with the latter being ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 April 2010
7 April 2010
20 May 2013
© 2013 thepharmaletter.com